Caprock Group LLC Purchases 1,288 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Caprock Group LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.1% in the third quarter, HoldingsChannel reports. The fund owned 22,294 shares of the healthcare conglomerate’s stock after buying an additional 1,288 shares during the period. Caprock Group LLC’s holdings in UnitedHealth Group were worth $13,035,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Delta Financial Group Inc. increased its holdings in shares of UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares during the period. Signature Resources Capital Management LLC boosted its stake in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares during the period. Saxony Capital Management LLC raised its stake in shares of UnitedHealth Group by 3.5% in the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after purchasing an additional 18 shares during the last quarter. GoalVest Advisory LLC lifted its stake in UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after acquiring an additional 18 shares during the period. Finally, Fiduciary Group LLC increased its position in UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after acquiring an additional 18 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $589.65 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company’s 50-day moving average is $582.75 and its 200 day moving average is $550.66. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market capitalization of $542.64 billion, a P/E ratio of 38.41, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm earned $6.56 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Bank of America dropped their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Truist Financial reissued a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Cantor Fitzgerald increased their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Finally, Barclays lowered their target price on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.